From: Stability indicating RP-UPLC method for simultaneous quantification of bempedoic acid and ezetimibe in bulk and pharmaceutical formulations
Marketed formulation (tablet)
Drug
Label claim (mg)
Amount found (mg)
*Assay (% w/w) ± SD
NEXLIZET™
Bempedoic acid
180
180.92
100.51
Ezetimibe
10
9.91
99.11